Delivery Order SPE2DE24D0013-SPE2D625F2VNB
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $3,400 to Cepheid Inc. on September 2, 2025, with an ultimate completion date of September 9, 2025. The contract, designated 4569302264, is for XPCOV2/FLU/RSV-10 products and services and carries a firm fixed-price structure with no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit molecular diagnostics...
- This delivery order, valued at $14,960, was awarded to Cepheid Inc. on September 4, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The order, designated XPCOV2/FLU/RSV-10, calls for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with an ultimate completion date of September 18, 2025. The contract employs firm fixed-price pricing with no set-aside designation. Cepheid, headquartered in Sunnyvale, California, is...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2VNBDelivery Order
The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. Cepheid, a leading manufacturer of molecular diagnostic systems based in Sunnyvale, specializes in advanced diagnostic technologies and test kits for infectious diseases, providing comprehensive solutions including GeneXpert diagnostic systems, reagents, and testing services to federal healthcare systems. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Veterans Health Administration, which currently maintain two major IDV agreements valued at $32.8 million and $2.5 million respectively, both focused on PCR testing and molecular diagnostics for infectious diseases including COVID-19, influenza, RSV, and other pathogens. Cepheid's established relationships with the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency demonstrate the company's consistent capability to support federal healthcare procurement requirements for diagnostic testing solutions across multiple service networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 9/8/25 |